28. December 2016
2017 edition: Transglutaminase Speciality Reagents catalogue
Read more

06. April 2016
Tissue transglutaminase inhibitors
Read more

01. February 2016
Tissue transglutaminase in Alzheimer’s Disease
Read more

05. November 2015
Factor XIIIa: novel target for anticoagulation?
Read more

17. August 2015
Microbial transglutaminase for site-specific protein conjugation
Read more

01. May 2015
Transglutaminase antibodies in ataxia
Read more

01. April 2015
Transglutaminases: current research and applications - future directions
Read more

  • News  

    • Press release: Dr. Falk Pharma and Zedira announce completion of phase 1b clinical trial of ZED1227 for the treatment of celiac disease and move on to proof of concept study
    • Pressemitteilung: Dr. Falk Pharma und Zedira geben den Abschluss der Phase 1b-Studie für ZED1227 zur Zöliakie-Therapie bekannt und planen Start der Wirksamkeitsstudie
  • Blog

  • Events  

    • Transglutaminases in Medicine

      03.08.2017 - 05.08.2017
      Debrecen, Hungary

    • 15th Congress on Amino Acids, Peptides and Proteins

      07.08.2017 - 11.08.2017
      Vienna, Austria

    • 17th International Celiac Disease Symposium

      08.09.2017 - 10.09.2017
      New Delhi, India

    • NLSDays 2017

      12.09.2017 - 14.09.2017
      Malmö, Sweden

    • BIO-Europe

      06.11.2017 - 08.11.2017
      Berlin, Germany

    • MEDICA

      13.11.2017 - 16.11.2017
      Düsseldorf, Germany

    • Gordon Research Conference on: Transglutaminases in Human Disease Processes

      16.06.2018 - 17.06.2018
      Les Diablerets, Switzerland